Portfolio (Quarterly)
Guide ↗
Vanguard Personalized Indexing Management, LLC
· CIK 0001767306| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 281 | LPRO | OPEN LENDING CORP | Financial Services | 11,703.0 | $15K | — | NEW | — | $1.25 | +44.8% |
| 282 | — | QUINCE THERAPEUTICS INC | — | 132,661.0 | $13K | — | NEW | — | $0.10 | — |
| 283 | OPK | OPKO HEALTH INC | Healthcare | 11,596.0 | $13K | — | NEW | — | $1.14 | -2.1% |
| 284 | MXCT | MAXCYTE INC | Healthcare | 18,793.0 | $13K | — | NEW | — | $0.70 | +48.0% |
| 285 | ATYR | ATYR PHARMA INC | Healthcare | 16,669.0 | $13K | — | NEW | — | $0.78 | -35.5% |
| 286 | CDLX | CARDLYTICS INC | Communication Services | 12,324.0 | $13K | — | NEW | — | $1.05 | -39.5% |
| 287 | SLQT | SELECTQUOTE INC | Financial Services | 19,708.0 | $12K | — | NEW | — | $0.63 | +76.3% |
| 288 | — | T3 DEFENSE INC | — | 16,711.0 | $12K | — | NEW | — | $0.72 | — |
| 289 | — | OLENOX INDUSTRIES INC | — | 10,439.0 | $11K | — | NEW | — | $1.04 | — |
| 290 | CXAI | CXAPP INC | Technology | 57,449.0 | $10K | — | NEW | — | $0.18 | -22.3% |
| 291 | — | OFFERPAD SOLUTIONS INC | — | 13,152.0 | $9K | — | NEW | — | $0.66 | — |
| 292 | CGTX | COGNITION THERAPEUTICS INC | Healthcare | 11,034.0 | $8K | — | NEW | — | $0.76 | +44.8% |
| 293 | — | LIMINATUS PHARMA INC. | — | 34,706.0 | $6K | — | NEW | — | $0.17 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
32.3%
Financial Services
12.7%
Healthcare
9.7%
Communication Services
9.7%
Consumer Cyclical
9.7%
Industrials
9.2%
Consumer Defensive
5.0%
Energy
4.5%
Utilities
2.9%
Basic Materials
2.4%